The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity
Open accessAbstract
The coordination chemistry of Cu and Zn metal ions with the amyloid β (Aβ) peptides has attracted a lot of attention in recent years due to its implications in Alzheimer's disease. A number of reports indicate that Cu and Zn have profound effects on Aβ aggregation. However, the impact of these metal ions on Aβ oligomerization and fibrillization is still not well understood, especially for the more rapidly aggregating and more neurotoxic Aβ42 peptide. Here we report the effect of Cu(2+) and Zn(2+) on Aβ42 oligomerization and aggregation using a series of methods such as Thioflavin T (ThT) fluorescence, native gel and Western blotting, transmission electron microscopy (TEM), and cellular toxicity studies. Our studies suggest that both Cu(2+) and Zn(2+) ions inhibit Aβ42 fibrillization. While presence of Cu(2+) stabilizes Aβ42 oligomers, Zn(2+) leads to formation of amorphous, non-fibrillar aggregates. The effects of temperature, buffer, and metal ion concentration and stoichiometry were also studied. Interestingly, while Cu(2+) increases the Aβ42-induced cell toxicity, Zn(2+) causes a significant decrease in Aβ42 neurotoxicity. While previous reports have indicated that Cu(2+) can disrupt β-sheets and lead to non-fibrillar Aβ aggregates, the neurotoxic consequences were not investigated in detail. The data presented herein including cellular toxicity studies strongly suggest that Cu(2+) increases the neurotoxicity of Aβ42 due to stabilization of soluble Aβ42 oligomers.
AI snapshot
Written from the paper’s full text.
TL;DR
Cu²⁺ and Zn²⁺ both inhibit Aβ42 fibrillization, but they divert aggregation toward different species: Cu²⁺ stabilizes soluble Aβ42 oligomers, whereas Zn²⁺ forms amorphous non-fibrillar aggregates. In N2A cell toxicity assays, Cu²⁺ increases Aβ42 neurotoxicity while Zn²⁺ decreases it.
Key findings
- ThT fluorescence was significantly lower for Aβ42 aggregates formed with Cu²⁺ or Zn²⁺, while pre-formed Aβ fibrils increased ThT fluorescence by 20-fold.
- Native gel/Western blotting and TEM showed that Cu²⁺ inhibits Aβ42 fibrillization and stabilizes small soluble Aβ42 oligomers; Zn²⁺ leads to amorphous, non-fibrillar aggregates.
- In N2A cells, monomeric Aβ42 gave 58 ± 2% survival, preformed Aβ42 oligomers 45 ± 6%, and Aβ42 fibrils 86 ± 8%; Aβ42 + Cu²⁺ gave 48 ± 2% survival, similar to preformed oligomers.
- Zn²⁺ reduced Aβ42 toxicity, with 80 ± 5% cell survival in both the presence and absence of Aβ42.
Methods
- Aβ42 and Aβ40 aggregation was monitored using ThT fluorescence, native gel electrophoresis/Western blotting, and transmission electron microscopy (TEM).
- Metal effects were tested with Cu²⁺ or Zn²⁺ at 0.25–2 equivalents relative to Aβ, under varied buffer, temperature, and incubation-time conditions.
- Cytotoxicity was measured with the Alamar Blue assay in mouse neuroblastoma Neuro2A (N2A) cells exposed to 20 μM Aβ42 species and metal ions.
Limitations
- The paper states that ThT fluorescence has limitations for metal–Aβ studies, including metal complex formation, paramagnetic quenching by Cu²⁺, pH effects, and inability to detect amorphous aggregates.
- The paper notes that prior conflicting results likely arise from different experimental conditions and methods used to measure Aβ aggregation.
- No dedicated limitations section is present; evident limitations include the in vitro aggregation assays and single N2A cell line, with no in vivo validation reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
11 of 34 cited sources checked · 8 supported · 0 flagged · accuracy not yet measured
- Findingown data
Aβ40 does not form oligomers either in the presence or absence of metal ions.
“Notably, the Aβ40 peptide does not form oligomers either in presence or in absence of metal ions (Fig. 2, lanes a–c), a similar behavior being observed for Aβ40 by SDS-PAGE.49”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [49] Bitan G Fradinger EA Spring SM Teplow DB Amyloid 2005 12 88 16011984 source
The section ‘SDS-PAGE induces formation of high molecular weight Aβ assemblies’ reports that Aβ40 migrated as a monomer on SDS-PAGE, supporting the cited comparison of gel behavior. It does not establish that Aβ40 cannot form oligomers with or without metal ions. The section on SDS- and non-SDS-based methods describes cross-linked Aβ40 oligomers and cautions that SDS-PAGE can misrepresent oligomerization state. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Conflicting results have been reported for Cu2+-mediated Aβ aggregation.
“Several studies showed that Zn2+ promotes formation of nonfibrillar aggregates,16,29–31 yet conflicting results have been reported for the Cu2+-mediated Aβ aggregation.21,28,32,33”
Quote in the paperSubstantial claim2 of 4 sources checked- cites [21] Hureau C Coord. Chem. Rev 2012 256 2164
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [28] Mold M Ouro-Gnao L Wieckowski BM Exley C Sci. Rep 2013 3 1256 23409247 PMC3570782 source
- cites [32] Zou J Kajita K Sugimoto N Angew. Chem., Int. Ed 2001 40 2274 11433492 source
- cites [33] Sarell CJ Wilkinson SR Viles JH J. Biol. Chem 2010 285 41533 20974842 PMC3009880 source
- Interpretationown data
Aβ42 oligomers are more neurotoxic than insoluble Aβ42 aggregates.
“supporting the more neurotoxic nature of Aβ42 oligomers.60,61”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
The Alamar Blue cell assay is more appropriate for Aβ toxicity studies than the MTT assay.
“The viability of Neuro-2A (N2A) cells57 was probed using the Alamar Blue cell assay, which was shown to be more appropriate for Aβ toxicity studies vs. the MTT assay.58,59”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [58] Wogulis M Wright S Cunningham D Chilcote T Powell K Rydel RE J. Neurosci 2005 25 1071 15689542 PMC6725948 source
- cites [59] Stine BW Jungbauer L Yu C LaDu MJ Methods Mol. Biol 2010 670 13 20967580 PMC3752843 source
The Materials (§2.8.1) and Methods (§3.8.1) describe an Aβ toxicity assay in N2A cells using CellTiter-Glo to measure cellular ATP. Searches for Alamar Blue and MTT found no passage comparing those assays or saying Alamar Blue is more appropriate, so our copy does not verify the attributed comparison. (LLM, conf=0.75)
Experimental — accuracy not yet measured
- Findingcitation
ThT fluorescence intensity increases by 20 fold in the presence of pre-formed Aβ fibrils.
“The fluorescence intensity of ThT increases by 20 fold in presence of pre-formed Aβ fibrils (Fig. 1), as observed previously for similar Aβ42 peptide concentrations.32”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Zou J Kajita K Sugimoto N Angew. Chem., Int. Ed 2001 40 2274 11433492 source
- Findingown data
All concentrations of Cu2+ from 0.25 to 2 equiv relative to Aβ42 were effective in reducing Aβ42 fibrillization, as monitored by ThT fluorescence and TEM.
“All concentrations of Cu2+ were effective in reducing Aβ42 fibrillization, as monitored by ThT fluorescence (Fig. 1) and TEM (Fig. 5).”
Quote in the paperSubstantial claim - Findingown data
The formation of insoluble aggregate and high MW oligomers (80-160 kDa) was inhibited by any amount of Cu2+ present.
“The formation of insoluble aggregate and high MW oligomers (80–160 kDa) was inhibited by any amount of Cu2+ present (Fig. 5), and higher concentrations of Cu2+ lead to an increased formation of smaller soluble Aβ42 oligomers (Fig. 5, lanes d–f).”
Quote in the paperSubstantial claim - Findingown data
The inhibition of Aβ42 aggregation by Cu2+ does not seem to be dependent on the buffer used.
“While some large Aβ42 aggregates were observed in 20 μM HEPES, overall the inhibition of Aβ42 aggregation by Cu2+ does not seem to be dependent on the buffer used.”
Quote in the paperNot a substantial claim - Findingown data
Aβ40 and Aβ42 both form fibrils after incubation for 24 h at 37 °C.
“Aβ40 and Aβ42 both form fibrils after incubation for 24 h at 37 °C (Fig. 2a and d).”
Quote in the paperNot a substantial claim - Findingown data
Aβ42 aggregates prepared in the presence of various amounts of Cu2+ and Zn2+ show significantly low ThT fluorescence.
“Interestingly, we observe a significantly low ThT fluorescence with the Aβ42 aggregates prepared in presence of various amounts of Cu2+ and Zn2+ (Fig. 1).”
Quote in the paperSubstantial claim - Findingown data
In the presence of Zn2+, both Aβ40 and Aβ42 form amorphous aggregates.
“In presence of Zn2+, both Aβ40 and Aβ42 form amorphous aggregates, as observed by TEM (panels c and f).”
Quote in the paperSubstantial claim - Findingown data
The Western blots of the dose-dependent experiments suggest that all Cu2+ concentrations inhibit Aβ42 aggregation.
“In addition, the Western blots of these dose-dependent experiments suggest that all Cu2+ concentrations inhibit the Aβ42 aggregation.”
Quote in the paperSubstantial claim - Findingown data
Aβ40 does not show formation of any oligomeric species in the Western blot.
“In the Western blot, although Aβ40 does not show formation of any oligomeric species, it shows a dark band at the top of gel (lane a).”
Quote in the paperSubstantial claim - Findingown data
In contrast to Aβ40, Aβ42 did not form amyloid fibrils in the presence of Cu2+, small Aβ42 aggregates being formed instead.
“In contrast to Aβ40, Aβ42 did not form amyloid fibrils in presence of Cu2+, small Aβ42 aggregates being formed instead as seen by TEM (panel e).”
Quote in the paperSubstantial claim - Findingown data
In the presence of Aβ42 and Cu2+, cell survival was markedly reduced to 48 ± 2%.
“While Cu2+ was not toxic to cells in the absence of Aβ42 – a 90 × 5% cell survival being observed in presence of Cu2+ (Fig. 8, lane 4), a markedly reduced 48 ± 2% cell survival was observed in the presence of Aβ42 and Cu2+ (Fig. 8, lane 5).”
Quote in the paperSubstantial claim - Findingown data
Aβ42 by itself forms large MW oligomers at room temperature.
“Aβ42 by itself forms large MW oligomers at room temperature (Fig. 7); this is in contrast with the incubation at 37 °C in which Aβ42 fibrils are formed instead (Fig. 4).”
Quote in the paperSubstantial claim - Findingown data
Higher concentrations of Cu2+ lead to an increased formation of smaller soluble Aβ42 oligomers.
“The formation of insoluble aggregate and high MW oligomers (80–160 kDa) was inhibited by any amount of Cu2+ present (Fig. 5), and higher concentrations of Cu2+ lead to an increased formation of smaller soluble Aβ42 oligomers (Fig. 5, lanes d–f).”
Quote in the paperSubstantial claim - Findingown data
Monomeric Aβ42 leads to 58 ± 2% cell survival.
“The cell toxicity results suggest that monomeric Aβ42 leads to 58 ± 2% cell survival, likely due to formation of soluble Aβ42 oligomers during the 40 h incubation with the cells (Fig. 8, lane 1).”
Quote in the paperSubstantial claim - Findingown data
The presence of as low as 0.25 equiv Zn2+ causes formation of amorphous aggregates, similar to higher concentrations of Zn2+.
“Interestingly, while Aβ42 fibrils were observed after incubation in absence of Zn2+ at room temperature for 1 day, presence of as low as 0.25 equiv. Zn2+ causes formation of amorphous aggregates as observed by TEM (Fig. 6), a similar behavior being observed in the presence of higher concentrations of Zn2+.”
Quote in the paperSubstantial claim - Findingown data
Cu2+ in an equimolar ratio to Aβ42 leads to an appreciable cell toxicity.
“However, our results suggest that Cu2+ in an equimolar ratio to Aβ42 also leads to an appreciable cell toxicity, strongly supporting our hypothesis that Cu2+ stabilizes Aβ42 oligomers and thus increases the neurotoxicity of Aβ42 aggregates.”
Quote in the paperSubstantial claim - Findingown data
The cell survival with Aβ42 fibrils (FAβ) is 86 ± 8%.
“In addition, the cell survival with preformed Aβ42 oligomers (OAβ) and Aβ42 fibrils (FAβ) is 45 ± 6% and 86 ± 8%, respectively (Fig. 8, lanes 2 and 3), supporting the more neurotoxic nature of Aβ42 oligomers.60,61”
Quote in the paperSubstantial claim - Findingown data
The Cu2+-mediated stabilization of soluble Aβ42 species also occurs in the presence of Zn2+ ions, as observed by TEM.
“In addition, the Cu2+-mediated stabilization of soluble Aβ42 species also occurs in presence of Zn2+ ions – as observed by TEM, and thus is expected to be physiologically relevant.”
Quote in the paperSubstantial claim - Findingown data
The cell survival with preformed Aβ42 oligomers (OAβ) is 45 ± 6%.
“In addition, the cell survival with preformed Aβ42 oligomers (OAβ) and Aβ42 fibrils (FAβ) is 45 ± 6% and 86 ± 8%, respectively (Fig. 8, lanes 2 and 3), supporting the more neurotoxic nature of Aβ42 oligomers.60,61”
Quote in the paperSubstantial claim - Interpretationown data
Cu2+ stabilizes soluble Aβ42 species at both room temperature and 37 °C.
“Overall, these experiments suggest that Cu2+ stabilizes soluble Aβ42 species at both temperatures and use of RT allows for a detailed study of the Cu2+-mediated oligomerization process.”
Quote in the paperSubstantial claim - Interpretationcitation
In the presence of diamagnetic Zn2+ ions, the decrease in ThT fluorescence suggests the formation of non-fibrillar aggregates.
“In the presence of diamagnetic Zn2+ ions, although the effect is slightly lower than for Cu2+, the decrease in ThT fluorescence suggests the formation of non-fibrilar aggregates (see below),48”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [48] Ha C Ryu J Park CB Biochemistry 2007 46 6118 17455909 source
- Interpretationown data
Cu2+ seems to reduce the aggregation of Aβ42 quite significantly.
“Thus, Cu2+ seems to reduce the aggregation of Aβ42 quite significantly.”
Quote in the paperSubstantial claim - Interpretationown data
Aβ42 is the oligomer-forming peptide rather than Aβ40.
“These results strongly support the fact that Aβ42 is the oligomer-forming peptide rather than Aβ40.”
Quote in the paperSubstantial claim - Interpretationown data
Metal ions inhibit the Aβ42 fibrillization process by stabilizing soluble Aβ42 aggregates or formation of amorphous aggregates.
“Overall, the TEM and Western blotting results suggest that metal ions inhibit the Aβ42 fibrillization process by stabilizing soluble Aβ42 aggregates or formation of amorphous aggregates.”
Quote in the paperSubstantial claim - Interpretationreasoning
The Cu2+-promoted increased neurotoxicity of soluble Aβ42 species may play an important role in the etiology of AD.
“Thus, this Cu2+-promoted increased neurotoxicity of soluble Aβ42 species may play an important role in the etiology of AD.”
Quote in the paperSubstantial claim- Rests on an assumption: In vitro Aβ42 aggregation and cell toxicity results can be extrapolated to the in vivo role of metal–Aβ42 interactions in AD.
- Rests on an assumption: The neurotoxic Aβ42 oligomers formed in vitro are the same species responsible for neurotoxicity in AD.
- Premisereasoning
No report has employed all these techniques under similar experimental conditions to provide a detailed picture of the neurotoxicity implications of Cu2+- and Zn2+-mediated formation of soluble and/or insoluble Aβ42 aggregates.
“However, no report has employed all these techniques under similar experimental conditions to provide a detailed picture of the neurotoxicity implications of the Cu2+- and Zn2+-mediated formation of soluble and/or insoluble Aβ42 aggregates.”
Quote in the paperNot a substantial claim - Interpretationown data
Cu2+ increases the neurotoxicity of Aβ42 due to stabilization of soluble Aβ42 oligomers.
“The data presented herein including cellular toxicity studies strongly suggest that Cu2+ increases the neurotoxicity of Aβ42 due to stabilization of soluble Aβ42 oligomers.”
Quote in the paperSubstantial claim - Interpretationreasoning
Cu2+ may lead to an increased Aβ42 neurotoxicity in vivo due to formation of Aβ42 oligomers.
“These studies rule out a preventive role of Cu2+ and suggest that Cu2+ may lead to an increased Aβ42 neurotoxicity in vivo due to formation of Aβ42 oligomers.”
Quote in the paperSubstantial claim- Rests on an assumption: In vitro Aβ42 aggregation and cell toxicity results can be extrapolated to the in vivo role of metal–Aβ42 interactions in AD.
- Interpretationown data
Zn2+ decreases Aβ42 toxicity by formation of non-toxic insoluble amorphous aggregates.
“Importantly, the cell toxicity assays show that Cu2+ leads to an enhanced toxicity due to formation of neurotoxic soluble Aβ42 oligomers, while Zn2+ decreases Aβ42 toxicity by formation of non-toxic insoluble amorphous aggregates.”
Quote in the paperSubstantial claim - Premisecitation
Bio-available metals (copper, zinc, and iron) are found in high concentration in amyloid plaques.
“Post-mortem examination of the brain suggested that bio-available metals (i.e., copper, zinc, and iron) are found in high concentration in the amyloid plaques.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [12] Lovell MA Robertson JD Teesdale WJ Campbell JL Markesbery WR J. Neurol. Sci 1998 158 47 9667777 source
- cites [13] Faller P Hureau C Dalton Trans 2009 1080 19322475 source
- cites [14] Faller P ChemBioChem 2009 10 2837 19877000 source
- cites [15] Zatta P Drago D Bolognin S Sensi SL Trends Pharmacol. Sci 2009 30 346 19540003 source
- Interpretationreasoning
Zn2+ reduces the toxicity of Aβ42 most likely by formation of non-toxic amorphous aggregates.
“Zn2+ reduces the toxicity of Aβ42 most likely by formation of non-toxic amorphous aggregates.”
Quote in the paperSubstantial claim
- May combine two claims. 20
- Classified as probably not a substantial claim. 5
May combine two claims.
InterpretationcitationThe decreased ThT fluorescence in the presence of Cu2+ can be accounted for by less fibril formation, although quenching by paramagnetic Cu2+ could also be involved.
“A decreased ThT fluorescence32,36 in presence of Cu2+ ions can be accounted for by less fibril formation, although a quenching of fluorescence by the paramagnetic Cu2+ ions could also be involved.47”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [32] Zou J Kajita K Sugimoto N Angew. Chem., Int. Ed 2001 40 2274 11433492 source
- cites [36] House E Mold M Collingwood J Baldwin A Goodwin S Exley C J. Alzheimers Dis 2009 18 811 19749401 PMC2857508 source
Citation 47 is attached to the possibility that paramagnetic Cu2+ quenches ThT fluorescence. The Discussion (page unavailable) attributes the decrease to changes in preformed fibrils and reports no evidence about paramagnetic quenching; a search for quenching and paramagnetism found no passage addressing that possibility. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [47] Pradines V Stroia AJ Faller P New J. Chem 2008 32 1189
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSoluble Aβ oligomers are more neurotoxic than amyloid plaques and most likely responsible for synaptic dysfunction and memory loss in AD.
“However, recent in vivo studies have shown that soluble Aβ oligomers are more neurotoxic than amyloid plaques and most likely responsible for synaptic dysfunction and memory loss in AD.7–11”
Quote in the paperNot a substantial claim2 of 5 sources checked- cites [7] Walsh DM Selkoe DJ J. Neurochem 2007 101 1172 17286590 source
- cites [8] Haass C Selkoe DJ Nat. Rev.: Mol. Cell Biol 2007 8 101 17245412 source
- cites [9] Borutaite V Morkuniene R Valincius G BioMol Concepts 2011 2 211 25962030 source
- cites [10] Lambert MP Barlow AK Chromy BA Edwards C Freed R Liosatos M Morgan TE Rozovsky I Trommer B Viola KL Wals P Zhang C Finch CE Krafft GA Klein WL Proc. Natl. Acad. Sci. U. S. A 1998 95 6448 9600986 PMC27787 source
- cites [11] Gong YS Chang L Viola KL Lacor PN Lambert MP Finch CE Krafft GA Klein WL Proc. Natl. Acad. Sci. U. S. A 2003 100 10417 12925731 PMC193576 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationZn2+ promotes formation of nonfibrillar aggregates.
“Several studies showed that Zn2+ promotes formation of nonfibrillar aggregates,16,29–31 yet conflicting results have been reported for the Cu2+-mediated Aβ aggregation.”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [16] Bush AI Pettingell WH Multhaup G Paradis MD Vonsattel JP Gusella JF Beyreuther K Masters CL Tanzi RE Science 1994 265 1464 8073293 source
- cites [29] Sharma AK Pavlova ST Kim J Finkelstein D Hawco NJ Rath NP Kim J Mirica LM J. Am. Chem. Soc 2012 134 6625 22452395 PMC3368506 source
- cites [30] Garai K Sahoo B Kaushalya SK Desai R Maiti S Biochemistry 2007 46 10655 17718543 source
- cites [31] Tõugu V Karafin A Zovo K Chung RS Howells C West AK Palumaa P J. Neurochem 2009 110 1784 19619132 source
May combine two claims.
PremisecitationAβ42 is more neurotoxic and has a higher tendency to aggregate than Aβ40.
“Although Aβ40 is present in larger amounts in the brain, Aβ42 was found to be more neurotoxic and have a higher tendency to aggregate.4,5”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [4] McGowan E Pickford F Kim J Onstead L Eriksen J Yu C Skipper L Murphy MP Beard J Das P Jansen K DeLucia M Lin WL Dolios G Wang R Eckman CB Dickson DW Hutton M Hardy J Golde T Neuron 2005 47 191 16039562 PMC1373682 source
- cites [5] Kuperstein I Broersen K Benilova I Rozenski J Jonckheere W Debulpaep M Vandersteen A Segers-Nolten I Van Der Werf K Subramaniam V Braeken D Callewaert G Bartic C D’Hooge R Martins IC Rousseau F Schymkowitz J De Strooper B EMBO J 2010 29 3408 20818335 PMC2957213 source
May combine two claims.
Findingown dataThe presence of Cu2+ limits the formation of insoluble aggregates and high MW oligomers and seems to stabilize small MW oligomers at room temperature.
“However, the presence of Cu2+ limits the formation of insoluble aggregates and high MW oligomers and seems to stabilize small MW oligomers (Fig. 4, panel b and lane b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the presence of Cu2+, Aβ40 forms fibrils although in a lower amount, and the nature of aggregates formed remains fibrillar.
“In presence of Cu2+, Aβ40 forms fibrils although in a lower amount as observed by TEM, yet the nature of aggregates formed remains fibrillar (Fig. 2, panel b).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWestern blot confirms the formation of small soluble Aβ42 oligomers in the presence of Cu2+, and the formation of high MW oligomers is inhibited.
“Western blot confirms the formation of small soluble Aβ42 oligomers (lane e), the formation of high MW oligomers being inhibited.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt 37 °C, Aβ42 forms amyloid fibrils within 24 h and large MW oligomers.
“At 37 °C the Aβ42 peptide forms amyloid fibrils within 24 h as observed in TEM, as well as large MW oligomers as seen in the Western blot (Fig. 4, panel c and lane c).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data0.25 equiv Cu2+ does not completely inhibit Aβ42 aggregation, while Cu2+ amounts larger than 0.5 equiv lead to formation of soluble Aβ42 species.
“While the presence of 0.25 equiv. Cu2+ (6.25 μM) does not completely inhibit Aβ42 aggregation, Cu2+ amounts larger than 0.5 equiv. lead to formation of soluble Aβ42 species.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWestern blotting of Zn2+-Aβ42 aggregates shows formation of small soluble Aβ42 oligomers, while high MW oligomers were not observed.
“Western blotting of Zn2+-Aβ42 aggregates shows formation of small soluble Aβ42 oligomers, while high MW oligomers were not observed.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe Western blot of Aβ42 shows formation of various size oligomers (trimer, tetramer, and higher MW oligomers) as well as a small band at gel entrance.
“The Western blot of Aβ42 shows formation of various size oligomers (trimer, tetramer, and higher MW oligomers) as well as a small band at gel entrance (lane d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe presence of Cu2+ leads to formation of small MW oligomers at 37 °C, suggesting that Cu2+ stabilizes Aβ42 oligomers even at 37 °C.
“By contrast, the presence of Cu2+ leads to formation of small MW oligomers, which suggests that Cu2+ stabilizes Aβ42 oligomers even at 37 °C (Fig. 4, lane d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAβ42 forms amorphous aggregates after incubation for 72 h at room temperature and forms a range of soluble oligomers.
“Aβ42 forms amorphous aggregates after incubation for 72 h at room temperature and forms a range of soluble oligomers (Fig. 4, panel a and lane a).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCu2+ was not toxic to cells in the absence of Aβ42, with 90 × 5% cell survival observed in the presence of Cu2+.
“While Cu2+ was not toxic to cells in the absence of Aβ42 – a 90 × 5% cell survival being observed in presence of Cu2+ (Fig. 8, lane 4), a markedly reduced 48 ± 2% cell survival was observed in the presence of Aβ42 and Cu2+ (Fig. 8, lane 5).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe presence of Cu2+ inhibits formation of the large MW oligomers and selectively stabilizes small MW oligomers even after four days.
“Interestingly, the presence of Cu2+ seems to inhibit formation of the large MW oligomers and selectively stabilizes small MW oligomers, even after four days (Fig. 7A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe presence of Cu2+ leads to a statistically significant decrease in cell viability, similar to that observed for preformed Aβ42 oligomers.
“Thus, the presence of Cu2+ leads to a statistically significant decrease in cell viability, which is similar to that observed for preformed Aβ42 oligomers (Fig. 8, lane 5 vs. lane 2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataZn2+ leads to disappearance of high MW oligomers, only small Aβ42 oligomers being observed, likely along with an appreciable amount of insoluble amorphous aggregates.
“On the other hand, Zn2+ leads to disappearance of high MW oligomers, only small Aβ42 oligomers being observed (Fig. 7B) that form likely along with an appreciable amount of insoluble amorphous aggregates (Fig. 6).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Study design and conductnone givenThe TEM images in Fig. 5 are representative of the entire surface of TEM grids that show a homogeneous distribution of the observed Aβ species.
“Importantly, the TEM images in Fig. 5 are representative of the entire surface of TEM grids that show a homogeneous distribution of the observed Aβ species.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataCu2+ has an inhibitory effect on Aβ42 fibrillization and leads to the formation of soluble Aβ42 oligomers.
“Overall, both TEM and native gel/Western blotting studies strongly suggest that Cu2+ has an inhibitory effect on Aβ42 fibrillization and leads to the formation of soluble Aβ42 oligomers.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMetal ions promote Aβ aggregation and formation of reactive oxygen species and lead to oxidative stress.
“For example, it was shown that that metal ions promote Aβ aggregation,16,17 as well as formation of reactive oxygen species (ROS) and lead to oxidative stress.18–20”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [16] Bush AI Pettingell WH Multhaup G Paradis MD Vonsattel JP Gusella JF Beyreuther K Masters CL Tanzi RE Science 1994 265 1464 8073293 source
- cites [17] Atwood CS Moir RD Huang XD Scarpa RC Bacarra NME Romano DM Hartshorn MK Tanzi RE Bush AI J. Biol. Chem 1998 273 12817 9582309 source
- cites [18] Hureau C Faller P Biochimie 2009 91 1212 19332103 source
- cites [19] Zhu X Su B Wang X Smith M Perry G Cell. Mol. Life Sci 2007 64 2202 17605000 PMC11136009 source
- cites [20] Crichton RR Dexter DT Ward RJ Coord. Chem. Rev 2008 252 1189
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
Study design and conductown dataThe study employed a wide range of techniques (ThT fluorescence, native gel electrophoresis and Western blotting, TEM, and cellular toxicity studies) to study the effect of metal ions on Aβ42 oligomerization and aggregation.
“Herein we have employed for the first time a wide range of techniques to study the effect of metal ions on the oligomerization and aggregation of the more neurotoxic Aβ42 peptide.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenAll solutions and buffers were prepared using metal-free Millipore water treated with Chelex and filtered to avoid metal contamination.
“All solutions and buffers were prepared using metal-free Millipore water that was treated with Chelex overnight and filtered through a 0.22 μm nylon filter.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataEven a substoichiometric amount of Zn2+ dramatically affects Aβ42 fibrillization and leads to formation of amorphous Aβ42 aggregates instead of soluble oligomers.
“The experiment suggests that even a substoichiometric amount of Zn2+ dramatically affects Aβ42 fibrillization and leads to formtion of amorphous Aβ42 aggregates instead of soluble oligomers.”
Quote in the paperSubstantial claim
The paper relies on this without support.
In vitro Aβ42 aggregation and cell toxicity results can be extrapolated to the in vivo role of metal–Aβ42 interactions in AD.
“Most importantly, we have correlated these in vitro results with neurotoxicity studies, in order to address to potential in vivo role of metal–Aβ42 interactions in AD.”
“These studies rule out a preventive role of Cu2+ and suggest that Cu2+ may lead to an increased Aβ42 neurotoxicity in vivo due to formation of Aβ42 oligomers.”
The paper relies on this without support.
The neurotoxic Aβ42 oligomers formed in vitro are the same species responsible for neurotoxicity in AD.
“The data presented herein including cellular toxicity studies strongly suggest that Cu2+ increases the neurotoxicity of Aβ42 due to stabilization of soluble Aβ42 oligomers.”
“Thus, this Cu2+-promoted increased neurotoxicity of soluble Aβ42 species may play an important role in the etiology of AD.”
The paper relies on this without support.
Viability of Neuro-2A cells is a valid measure of Aβ42 neurotoxicity relevant to Alzheimer’s disease.
“The viability of Neuro-2A (N2A) cells57 was probed using the Alamar Blue cell assay, which was shown to be more appropriate for Aβ toxicity studies vs. the MTT assay.58,59”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The majority of these BFCs have been studied for their effect on aggregation of the Aβ40 peptide, and fewer studies have focused on their interaction with the more neurotoxic Aβ42 peptide.
“However, the majority of these BFCs have been studied for their effect on aggregation of the Aβ40 peptide,25,31 and fewer studies have focused on their interaction with the more neurotoxic Aβ42 peptide.20,21”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [21]
The Introduction (page unavailable) says Aβ42 is more neurotoxic than Aβ40, and the Results and discussion section says this study focuses mainly on how Cu2+ and Zn2+ affect Aβ42 aggregation. The cited paper does not establish that fewer studies have examined BFC interactions with Aβ42, nor does it study BFCs itself. (LLM, conf=0.84)
Experimental — accuracy not yet measuredIn inhibition experiments, reduced ThT fluorescence was observed for Cu2+- and Zn2+-containing fibrils.
“In inhibition experiments, a reduced ThT fluorescence was observed for the Cu2+- and Zn2+-containing fibrils, as reported previously (Figure 6).21,49,50”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [21]
The Introduction and the Results and discussion section on ThT fluorescence report reduced fluorescence for Aβ42 aggregates prepared with Cu2+ and Zn2+. They do not establish that the measured material was fibrils: the paper says the metals inhibit fibrillization, with Zn2+ promoting amorphous aggregates and Cu2+ stabilizing soluble species. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThe approach of inhibiting metal-mediated Aβ40 aggregation or promoting disaggregation may not be optimal for the Aβ42 peptide, given the increased toxicity observed for soluble Aβ42 oligomers.
“However, this approach may not be optimal for the Aβ42 peptide, given the increased toxicity observed for soluble Aβ42 oligomers.20,21”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [21]
Cu2+ ions slow down fibrillization of Aβ42 peptide and stabilize soluble Aβ42 species.
“We have also recently reported that Cu2+ ions slow down fibrillization of the Aβ42 peptide and stabilize the soluble Aβ42 species, as observed by native gel electrophoresis/Western blotting, TEM, cell viability studies,20,21 and pulsed hydrogen/deuterium exchange mass spectrometry studies.22”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [21]
The presence of Cu2+ ions inhibits the formation of large soluble and insoluble Aβ42 aggregates.
“the presence of Cu2+ ions inhibits the formation of large soluble and insoluble Aβ42 aggregates (Figure 7, lane 2).”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [21]
Cu2+-Aβ species have been shown to be neurotoxic.
“Because Cu2+–Aβ species have been shown to be neurotoxic,20,21,31,51,52”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [21]
Aβ42 peptide is more prone to form neurotoxic soluble Aβ oligomers than the Aβ40 peptide.
“Although it was shown in previous studies9,10,21 that the Aβ42 peptide is more prone to form neurotoxic soluble Aβ oligomers than the Aβ40 peptide”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [21]
The presence of Cu2+ and Zn2+ does not inhibit Aβ40 aggregation, yet they change the morphology of the insoluble aggregates that become more amorphous.
“the presence of Cu2+ and Zn2+ does not inhibit Aβ40 aggregation,21 yet they change the morphology of the insoluble aggregates that become more amorphous (Figure S9 in the SI, panels 2 and 3).”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Cites a retracted work: 10.1038/nature04533
InfoThe cited work was retracted on 2024-06-24 (notice 10.1038/s41586-024-07691-8), not before this paper was published (2013).
Cited work 10.1038/nature04533 · retracted 2024-06-24 · notice 10.1038/s41586-024-07691-8 · this paper published 2013
“Lesne, 2006, Nature, 440, 352, 10.1038/nature04533”
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · see citing works
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336 · see citing works
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120 · see citing works
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942 · see citing works
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938 · see citing works
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522 · see citing works
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452 · see citing works
[18] Quantification of β-sheet amyloid fibril structures with thioflavin T
LeVine, H. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09020-5 · Cited by 1,365 · see citing works
Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1799 · Cited by 1,111 · see citing works
Huang, X., Atwood, C., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J. T., Moir, R. D., et al. (1999) · Biochemistry · doi:10.1021/bi990438f · Cited by 1,107 · see citing works
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · see citing works
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009 · see citing works
Bush, A. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00073-3 · Cited by 731 · see citing works
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680 · see citing works
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672 · see citing works
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 565 · see citing works
Self-citationAβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets
Klein, W. L. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00050-5 · Cited by 541 · see citing works
Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.211 · Cited by 532 · see citing works
Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide
Faller, P., & Hureau, C. (2009) · Dalton Trans. · doi:10.1039/b813398k · Cited by 530 · see citing works
Preparing Synthetic Aβ in Different Aggregation States
Stine, W. B., Jungbauer, L., Yu, C., & LaDu, M. J. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-744-0_2 · Cited by 403 · see citing works
Redox-active iron mediates amyloid-β toxicity
Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C., Chevion, M., Perry, G. L., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00494-9 · Cited by 376 · see citing works
Alzheimer's disease, metal ions and metal homeostatic therapy
Zatta, P., Drago, D., Bolognin, S., & Sensi, S. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.002 · Cited by 369 · see citing works
Aβ40 Inhibits Amyloid Deposition<i>In Vivo</i>
Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D. W., Golde, T., & McGowan, E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4849-06.2007 · Cited by 359 · see citing works
Self-citationCauses of oxidative stress in Alzheimer disease
Zhu, X., Su, B., Wang, X., Smith, M. A., & Perry, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7218-4 · Cited by 336 · see citing works
Metal complexing agents as therapies for Alzheimer’s disease
Bush, A. I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00120-3 · Cited by 310 · see citing works
Zou, K., Gong, J.-S., Yanagisawa, K., & Michikawa, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04833.2002 · Cited by 305 · see citing works
Faller, P. (2009) · ChemBioChem · doi:10.1002/cbic.200900321 · Cited by 285 · see citing works
Choi, J.-S., Braymer, J. J., Nanga, R. P. R., Ramamoorthy, A., & Lim, M. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006091107 · Cited by 264 · see citing works
Hureau, C., & Faller, P. (2009) · Biochimie · doi:10.1016/j.biochi.2009.03.013 · Cited by 259 · see citing works
Metal based neurodegenerative diseases—From molecular mechanisms to therapeutic strategies
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2008) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.10.019 · Cited by 252 · see citing works
New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
Yoshiike, Y., Tanemura, K., Murayama, O., Akagi, T., Murayama, M., Sato, S., Sun, X., Tanaka, N., & Takashima, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010706200 · Cited by 244 · see citing works
Zinc takes the center stage: its paradoxical role in Alzheimer’s disease
Cuajungco, M. P., & Faget, K. Y. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00219-9 · Cited by 242 · see citing works
Wogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., & Rydel, R. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2381-04.2005 · Cited by 233 · see citing works
Ha, C., Ryu, J., & Park, C. B. (2007) · Biochemistry · doi:10.1021/bi7000032 · Cited by 231 · see citing works
Neurotoxic protein oligomers — what you see is not always what you get
Bitan, G., Fradinger, E. A., Spring, S. M., & Teplow, D. B. (2005) · Amyloid · doi:10.1080/13506120500106958 · Cited by 221 · see citing works
Identifying the Minimal Copper- and Zinc-binding Site Sequence in Amyloid-β Peptides
Minicozzi, V., Stellato, F., Comai, M., Serra, M. D., Potrich, C., Meyer‐Klaucke, W., & Morante, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707109200 · Cited by 209 · see citing works
Small Molecule Modulators of Copper-Induced Aβ Aggregation
Hindo, S. S., Mancino, A. M., Braymer, J. J., Liu, Y., Vivekanandan, S., Ramamoorthy, A., & Lim, M. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907045h · Cited by 203 · see citing works
Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ<sub>42</sub>Peptide
Sharma, A. K., Pavlova, S. T., Kim, J., Finkelstein, D., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210588m · Cited by 202 · see citing works
Self-citationSarell, C. J., Wilkinson, S. R., & Viles, J. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.171355 · Cited by 199 · see citing works
Smith, D. P., Ciccotosto, G. D., Tew, D. J., Fodero‐Tavoletti, M. T., Johanssen, T., Masters, C. L., Barnham, K. J., & Cappai, R. (2007) · Biochemistry · doi:10.1021/bi0620961 · Cited by 193 · see citing works
Tõugu, V., Karafin, A., Zovo, K., Chung, R. S., Howells, C., West, A. K., & Palumaa, P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06269.x · Cited by 181 · see citing works
Hureau, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.037 · Cited by 178 · see citing works
Amyloid-β Binds Cu <sup>2+</sup> in a Mononuclear Metal Ion Binding Site
Karr, J. W., Kaupp, L. J., & Szalai, V. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0488028 · Cited by 160 · see citing works
Storr, T., Merkel, M., Song-Zhao, G. X., Scott, L. E., Green, D. E., Bowen, M. L., Thompson, K. H., Patrick, B. O., Schugar, H. J., & Orvig, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068965r · Cited by 156 · see citing works
Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151 · see citing works
Amyloid β Protein: Aβ40 Inhibits Aβ42 Oligomerization
Murray, M. M., Bernstein, S. L., Nyugen, V., Condron, M. M., Teplow, D. B., & Bowers, M. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8092604 · Cited by 128 · see citing works
Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β Peptides
Pedersen, J. T., Østergaard, J., Rozlosnik, N., Gammelgaard, B., & Heegaard, N. H. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220863 · Cited by 121 · see citing works
Zinc Lowers Amyloid-β Toxicity by Selectively Precipitating Aggregation Intermediates
Garai, K., Sahoo, B., Kaushalya, S. K., Desai, R., & Maiti, S. (2007) · Biochemistry · doi:10.1021/bi700798b · Cited by 110 · see citing works
Mold, M., Ouro-Gnao, L., Wieckowski, B. M., & Exley, C. (2013) · Scientific Reports · doi:10.1038/srep01256 · Cited by 101 · see citing works
Aβ40 Protects Non-toxic Aβ42 Monomer from Aggregation
Yan, Y., & Wang, C. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.04.014 · Cited by 99 · see citing works
Innocenti, M., Salvietti, E., Guidotti, M., Casini, A., Bellandi, S., Foresti, M. L., Gabbiani, C., Pozzi, A., Zatta, P. F., & Luigi Messori, A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1338 · Cited by 87 · see citing works
Aliès, B., Eury, H., Bijani, C., Rechignat, L., Faller, P., & Hureau, C. (2011) · Inorganic Chemistry · doi:10.1021/ic201739n · Cited by 80 · see citing works
Copper(II) Coordination to Amyloid β: Murine versus Human Peptide
Eury, H., Bijani, C., Faller, P., & Hureau, C. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201005838 · Cited by 79 · see citing works
Pro‐apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity
Kuperstein, F., & Yavin, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01831.x · Cited by 50 · see citing works
Copper Abolishes the β-Sheet Secondary Structure of Preformed Amyloid Fibrils of Amyloid-β42
House, E., Mold, M., Collingwood, J., Baldwin, A., Goodwin, S., & Exley, C. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1235 · Cited by 45 · see citing works
Amyloid fibrils: modulation of formation and structure by copper(ii)
Pradines, V., Stroia, A. J., & Faller, P. (2008) · New Journal of Chemistry · doi:10.1039/b719556g · Cited by 25 · see citing works
Dynamics of ZnII Binding as a Key Feature in the Formation of Amyloid Fibrils by Aβ11-28
Aliès, B., Solari, P., Hureau, C., & Faller, P. (2011) · Inorganic Chemistry · doi:10.1021/ic202247m · Cited by 25 · see citing works
Beta-amyloid oligomers: recent developments
Borutaite, V., Morkuniene, R., & Valincius, G. (2011) · bmc · doi:10.1515/bmc.2011.019 · Cited by 9 · see citing works
Flagged first, then by citations
1 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Rajasekhar, K., Chakrabarti, M., & Govindaraju, T. (2015) · Chemical Communications · doi:10.1039/c5cc05264e · Cited by 241 · see citing works
Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions
Abeysinghe, A. A. D. T., Deshapriya, S., & Udawatte, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117996 · Cited by 239 · see citing works
Chen, L.-L., Fan, Y.-G., Zhao, L.-X., Zhang, Q., & Wang, Z.-Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106301 · Cited by 200 · see citing works
Atrián‐Blasco, E., Gonzalez, P., Santoro, A., Aliès, B., Faller, P., & Hureau, C. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.04.007 · Cited by 168 · see citing works
“The influence of Cu(II) on the Aβ aggregation seems to be mainly dependent on its concentration [144], and leads to the production of highly cytotoxic oligomers [139,145,146].”
BackgroundAlzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 151 · see citing works
Factors affecting the efficiency of a bioelectrochemical system: a review
Zhang, X., Li, X., Zhao, X., et al. (2019) · RSC Advances · doi:10.1039/c9ra03605a · Cited by 138 · see citing works
Zhang, Z., Zhou, F., Liu, X., & Zhao, M. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.03.030 · Cited by 136 · see citing works
Zinc, Carnosine, and Neurodegenerative Diseases
Kawahara, M., Tanaka, K.-I., & Kato-Negishi, M. (2018) · Nutrients · doi:10.3390/nu10020147 · Cited by 134 · see citing works
“Cu-oligomerized AβP is more toxic compared with Zn-oligomerized AβP [59].”
BackgroundAlzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123 · see citing works
Benseny‐Cases, N., Klementieva, O. L., Cotte, M., Ferrer, I., & Cladera, J. (2014) · Analytical Chemistry · doi:10.1021/ac502667b · Cited by 121 · see citing works
Metal ions influx is a double edged sword for the pathogenesis of Alzheimer’s disease
Wang, P., & Wang, Z. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.003 · Cited by 122 · see citing works
Rana, M., & Sharma, A. (2019) · Metallomics · doi:10.1039/c8mt00203g · Cited by 80 · see citing works
Self-citationSun, L., Cho, H.-J., Sen, S., Arango, A. S., Huynh, T. T., Huang, Y., Bandara, N., Rogers, B. E., Tajkhorshid, E., & Mirica, L. M. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05470 · Cited by 100 · see citing works
“A β 42 species were shown to be neurotoxic, 71 it is important to develop novel metal-chelating compounds that can control the Cu 2+ -induced A β 42 cytotoxicity.”
Self-citationMulti-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
Jones, M. R., Mathieu, É., Dyrager, C., Faissner, S., Vaillancourt, Z., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., Yong, V. W., Tsutsui, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01269a · Cited by 96 · see citing works
Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level
Atrián‐Blasco, E., Conte‐Daban, A., & Hureau, C. (2017) · Dalton Transactions · doi:10.1039/c7dt01344b · Cited by 96 · see citing works
Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer’s Drug Discovery
Bu, X., Rao, P. P. N., & Wang, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9301-4 · Cited by 93 · see citing works
Xu, P., Zhang, M., Sheng, R., & Ma, Y. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.045 · Cited by 92 · see citing works
Gomes, L. M., Vieira, R. P., Jones, M. R., Wang, M. C. P., Dyrager, C., de Souza-Fagundes, E. M., Silva, J. G. D., Storr, T., & Beraldo, H. D. O. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.04.011 · Cited by 92 · see citing works
Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic
Kepp, K. P., & Squitti, R. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.06.018 · Cited by 90 · see citing works
Kawahara, M., Kato-Negishi, M., & Tanaka, K. (2017) · Metallomics · doi:10.1039/c7mt00046d · Cited by 80 · see citing works
Meng, K., Chen, L., Xia, G., et al. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.129043 · Cited by 75 · see citing works
Bandara, N., Sharma, A. K., Krieger, S., Schultz, J. W., Han, B. H., Rogers, B. E., & Mirica, L. M. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05937 · Cited by 76 · see citing works
Self-citationMorris, D. R., & Levenson, C. W. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_15 · Cited by 70 · see citing works
Scassellati, C., Bonvicini, C., Benussi, L., Ghidoni, R., & Squitti, R. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126499 · Cited by 66 · see citing works
Fang, S., Ruan, G.-R., Hao, J., et al. (2020) · LWT · doi:10.1016/j.lwt.2020.109632 · Cited by 65 · see citing works
Matheou, C. J., Younan, N. D., & Viles, J. H. (2014) · Biochemical Journal · doi:10.1042/bj20141168 · Cited by 63 · see citing works
Li, J., Chen, G., Wang, Z., Gao, R., Ren, J., Zhou, X., Wang, H., Xu, H. J., Xiao, F., Cao, Y., et al. (2019) · Marine Drugs · doi:10.3390/md17060341 · Cited by 64 · see citing works
“Metal ions can interact with peptides and facilitate peptide aggregation [25].”
BackgroundBarritt, J. D., & Viles, J. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.684084 · Cited by 62 · see citing works
Sharma, A. K., Schultz, J. W., Prior, J. T., Rath, N. P., & Mirica, L. M. (2017) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.7b01883 · Cited by 60 · see citing works
Self-citationHuang, Y., Cho, H.-J., Bandara, N., Sun, L., Tran, D., Rogers, B. E., & Mirica, L. M. (2020) · Chemical Science · doi:10.1039/d0sc02641g · Cited by 58 · see citing works
Self-citationPochwat, B., Nowak, G., & Szewczyk, B. (2015) · Neural Plasticity · doi:10.1155/2015/591563 · Cited by 54 · see citing works
Abelein, A., Ciofi-Baffoni, S., Mörman, C., Kumar, R., Giachetti, A., Piccioli, M., & Biverstål, H. (2022) · JACS Au · doi:10.1021/jacsau.2c00438 · Cited by 52 · see citing works
CuII Binding Properties of N-Truncated Aβ Peptides: In Search of Biological Function
Stefaniak, E., & Bal, W. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01399 · Cited by 53 · see citing works
Cho, H., Sharma, A. K., Zhang, Y., Gross, M. L., & Mirica, L. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00114 · Cited by 53 · see citing works
Self-citationDietary Trace Elements and the Pathogenesis of Neurodegenerative Diseases
Kawahara, M., Kato‐Negishi, M., & Tanaka, K. (2023) · Nutrients · doi:10.3390/nu15092067 · Cited by 52 · see citing works
Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity
Jones, M. R., Mu, C., Wang, M. C. P., Webb, M. I., Walsby, C. J., & Storr, T. (2015) · Metallomics · doi:10.1039/c4mt00252k · Cited by 50 · see citing works
Effects of Cu(II) on the aggregation of amyloid-β
Weibull, M. G. M., Simonsen, S., Oksbjerg, C. R., Tiwari, M. K., & Hemmingsen, L. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01727-5 · Cited by 50 · see citing works
Sharma, A. K., Kim, J., Prior, J. T., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2014) · Inorganic Chemistry · doi:10.1021/ic500926c · Cited by 48 · see citing works
Self-citationSong, M. K., Bischoff, D. S., Song, A. M., Uyemura, K., & Yamaguchi, D. T. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.09.003 · Cited by 48 · see citing works
Structure characterization and antioxidant activity of abalone visceral peptides-selenium in vitro
Jia, J., Liu, Q., Liu, H., et al. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.137398 · Cited by 44 · see citing works
Sun, L., Sharma, A. K., Han, B.-H., & Mirica, L. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00376 · Cited by 45 · see citing works
Self-citationQu, W., Li, Y., Xiong, T., Feng, Y., Ma, H., & Akpabli‐Tsigbe, N. D. K. (2022) · Food Research International · doi:10.1016/j.foodres.2022.112033 · Cited by 41 · see citing works
Cross-Reactive Fluorescent Sensor Array for Discrimination of Amyloid Beta Aggregates
Zhang, P., & Tan, C. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00579 · Cited by 40 · see citing works
Azo-dyes based small bifunctional molecules for metal chelation and controlling amyloid formation
Rana, M., Cho, H., Roy, T. K., Mirica, L. M., & Sharma, A. K. (2017) · Inorganica Chimica Acta · doi:10.1016/j.ica.2017.11.029 · Cited by 40 · see citing works
Self-citationHydrophilic Food-Borne Nanoparticles from Beef Broth as Novel Nanocarriers for Zinc
Geng, J., Song, X., Zhang, X., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01372 · Cited by 38 · see citing works
Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro
Sasanian, N., Bernson, D., Horváth, I., Wittung-Stafshede, P. E., & Esbjörner, E. K. (2020) · Biomolecules · doi:10.3390/biom10060924 · Cited by 38 · see citing works
“Cu2+ has also been reported to selectively induce the formation of cytotoxic Aβ(1-42) oligomers under conditions where Zn2+ did not [55], thereby putatively contributing specifically to toxicity.”
BackgroundSi, K., Gong, T., Ding, S., et al. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134567 · Cited by 35 · see citing works
Matheou, C. J., Younan, N. D., & Viles, J. H. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.017 · Cited by 33 · see citing works
Yang, T., Zhang, L., Shang, Y., Zhu, Z., Jin, S., Guo, Z., & Wang, X. (2022) · Chemical Science · doi:10.1039/d1sc06071f · Cited by 34 · see citing works
Jones, M. R., Dyrager, C., Hoarau, M., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., & Storr, T. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.022 · Cited by 34 · see citing works
Kaur, A., Narang, S. S., Kaur, A., Mann, S., Priyadarshi, N., Goyal, B., Singhal, N. K., & Goyal, D. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00168 · Cited by 33 · see citing works
Amyloids: Regulators of Metal Homeostasis in the Synapse
Kawahara, M., Kato‐Negishi, M., & Tanaka, K. (2020) · Molecules · doi:10.3390/molecules25061441 · Cited by 31 · see citing works
Lignin-Based CdS Dots as Multifunctional Platforms for Sensing and Wearable Photodynamic Coatings
Paul, S., Thakur, N. S., Chandna, S., et al. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c04427 · Cited by 32 · see citing works
Rana, M., Cho, H., Arya, H., Bhatt, T. K., Bhar, K., Bhatt, S., Mirica, L. M., & Sharma, A. K. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c00502 · Cited by 33 · see citing works
Self-citationHistidine‐Rich Oligopeptides To Lessen Copper‐Mediated Amyloid‐β Toxicity
Caballero, A. B., Terol‐Ordaz, L., Espargaró, A., Vázquez, G., Nicolás, E., Sabaté, R., & Gámez, P. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201600286 · Cited by 30 · see citing works
Wang, C., Cheng, F., Xu, L., & Jia, L. (2016) · RSC Advances · doi:10.1039/c6ra14590f · Cited by 30 · see citing works
Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer’s disease
Cheng, G., Xu, P., Zhang, M., Chen, J., Sheng, R., & Ma, Y. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.08.011 · Cited by 30 · see citing works
Gao, J., Ning, C., Wang, M., et al. (2024) · Food Chemistry X · doi:10.1016/j.fochx.2024.101706 · Cited by 29 · see citing works
“This could be because metal ions can interact with peptides and substantially affect their aggregation (Sharma, Pavlova, Kim, Kim, & Mirica, 2013).”
BackgroundA Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu2+-Mediated Aβ Aggregation
Zhang, X., Zhang, X., Zhong, M., Zhao, P., Guo, C., Li, Y., Xu, H. J., Wang, T., & Gao, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136842 · Cited by 30 · see citing works
“Therefore, the ThT fluorescence intensity was not as high as that in the presence of Aβ1-42 alone, which is consistent with previous studies [49,50].”
ResultThe Function of Transthyretin Complexes with Metallothionein in Alzheimer’s Disease
Zaręba, N., & Kepinská, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239003 · Cited by 28 · see citing works
“Furthermore, Cu2+ binding significantly accelerates the rate of fiber formation and enhances cytotoxicity in cell culture [24].”
BackgroundA Highly Efficient BODIPY Based Turn-off Fluorescent Probe for Detecting Cu2+
Sun, R., Wang, L., Jiang, C., Du, Z., Chen, S., & Wu, W. (2020) · Journal of Fluorescence · doi:10.1007/s10895-020-02544-9 · Cited by 26 · see citing works
Cline, E. N., Das, A., Bicca, M. A., Mohammad, S. N., Schachner, L. F., Kamel, J. M., DiNunno, N., Weng, A., Paschall, J. D., Bu, R. L., et al. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14647 · Cited by 25 · see citing works
Dey, J., Kumar, S., Aswal, V. K., et al. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp01666e · Cited by 25 · see citing works
Stefaniak, E., Atrián‐Blasco, E., Goch, W., Sabater, L., Hureau, C., & Bal, W. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202004484 · Cited by 26 · see citing works
Binuclear ruthenium complexes inhibit the fibril formation of human islet amyloid polypeptide
Gong, G., Wang, W., & Du, W. (2017) · RSC Advances · doi:10.1039/c6ra28107a · Cited by 24 · see citing works
Guan, C., Dang, R., Cui, Y., Liu, L., Chen, X., Wang, X., Zhu, J., Li, D., Li, J., & Wang, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178271 · Cited by 26 · see citing works
Wang, B., Xiao, S., Chen, X., et al. (2022) · International Journal of Food Science & Technology · doi:10.1111/ijfs.15644 · Cited by 22 · see citing works
Yu, Z., Guo, W., Patel, S., Cho, H., Sun, L., & Mirica, L. M. (2022) · Chemical Science · doi:10.1039/d2sc02654f · Cited by 23 · see citing works
Self-citationImplications of Metal Binding and Asparagine Deamidation for Amyloid Formation
Sadakane, Y., & Kawahara, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082449 · Cited by 22 · see citing works
“Cu-aggregated AβP is reportedly more toxic than Zn-aggregated AβP [61].”
BackgroundCoskuner‐Weber, O. (2016) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-016-1392-5 · Cited by 22 · see citing works
Li, X., Wang, W., Dong, X., & Sun, Y. P. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02397f · Cited by 20 · see citing works
Pietropaolo, A., Satriano, C., Strano, G., Mendola, D. L., & Rizzarelli, E. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.08.013 · Cited by 20 · see citing works
Influence of manganese exposure on cognitive function, plasma APP and Aβ levels in older men
Zhang, J., Yang, Y., Yang, X., Qin, J., Wei, X., Peng, Y., Li, Z., Zhang, L., Zhang, Z., & Zou, Y. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126788 · Cited by 20 · see citing works
Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases
Zhang, H.-L., Wang, X., & Liu, R. (2022) · Biomolecules · doi:10.3390/biom12060785 · Cited by 20 · see citing works
Spiegel, M., Marino, T., Prejanò, M., & Russo, N. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp01918c · Cited by 19 · see citing works
Is interaction of amyloid β-peptides with metals involved in cognitive activity?
Tamano, H., & Takeda, A. (2015) · Metallomics · doi:10.1039/c5mt00076a · Cited by 19 · see citing works
Márquez, M., Blancas‐Mejía, L. M., Campos, A., Rojas-Ochoa, L. F., Castañeda‐Hernández, G., & Quintanar, L. (2014) · Metallomics · doi:10.1039/c4mt00257a · Cited by 20 · see citing works
Bioinorganic Chemistry of Micronutrients Related to Alzheimer’s and Parkinson’s Diseases
Kola, A., Nencioni, F., & Valensin, D. (2023) · Molecules · doi:10.3390/molecules28145467 · Cited by 18 · see citing works
Coupling of Zinc-Binding and Secondary Structure in Nonfibrillar Aβ40 Peptide Oligomerization
Xu, L., Shan, S., Chen, Y., Wang, X., Nussinov, R., & Ma, B. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00063 · Cited by 18 · see citing works
Tian, Y., Shang, Q., Liang, R., & Viles, J. H. (2024) · JACS Au · doi:10.1021/jacsau.3c00687 · Cited by 18 · see citing works
Physiological and Pathological Functions of Beta-Amyloid in the Brain and Alzheimer'S Disease
Volicer, L. (2020) · The Chinese Journal of Physiology · doi:10.4103/cjp.cjp_10_20 · Cited by 18 · see citing works
Removal of nickel and copper ions in strongly acidic conditions by in-situ formed amyloid fibrils
Fan, Y., Lan, H., Qi, Z., et al. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.134241 · Cited by 17 · see citing works
New Hydroxyquinoline‐Based Derivatives as Potent Modulators of Amyloid‐β Aggregations
Fu, C.-L., Hsu, L., Liao, Y.-F., & Hu, M.-K. (2016) · Archiv der Pharmazie · doi:10.1002/ardp.201500453 · Cited by 14 · see citing works
Intertwined Pathologies of Amyloid-β and Metal Ions in Alzheimer’s Disease: Metal–Amyloid-β
Nam, G., & Lim, M.-H. (2019) · Chemistry Letters · doi:10.1246/cl.190281 · Cited by 12 · see citing works
Rana, M., Pareek, A., Bhardwaj, S., Arya, G., Nimesh, S., Arya, H., Bhatt, T. K., Yaragorla, S., & Sharma, A. K. (2020) · RSC Advances · doi:10.1039/d0ra05172a · Cited by 17 · see citing works
Self-citationCarvalho, A., Barbosa, B. M., Flores, J. S., Gonçalves, P. D. C., Diniz, R., Cordeiro, Y., Fernández, C. O., Cukierman, D. S., & Rey, N. A. (2022) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2022.112033 · Cited by 15 · see citing works
General chelating action of copper, zinc and iron in mammalian cells
Bertuchi, F. R., Papai, R., Ujevic, M., et al. (2014) · Analytical Methods · doi:10.1039/c4ay01912a · Cited by 15 · see citing works
Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia
Yoo, C. J., Choi, Y., Bok, E., Lin, Y., Cheon, M., Lee, Y., & Kim, J. (2024) · FEBS Journal · doi:10.1111/febs.17150 · Cited by 15 · see citing works
“Amyloid b (1 – 42) (A b 42) oligomers were prepared from recombinant amyloid b (1 – 42) monomers as described previously [112].”
Self-citationWang, Y., Chen, M., Liu, Y., et al. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106150 · Cited by 14 · see citing works
Spiegel, M., Ciardullo, G., Marino, T., et al. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1122880 · Cited by 14 · see citing works
“It is also referred to as a secondary antioxidant effect and is also relevant to the possible treatment of Alzheimer’s disease based on complexation of these metals (Sharma et al., 2013; Spiegel et al., 2022a):”
BackgroundCary, B. P., Brooks, A. F., Fawaz, M. V., Shao, X., Desmond, T. J., Carpenter, G. M., Sherman, P. S., Quesada, C., Albin, R. L., & Scott, P. J. H. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500413d · Cited by 14 · see citing works
Huang, Y., Huynh, T. T., Sun, L., Hu, C., Wang, Y.-C., Rogers, B. E., & Mirica, L. M. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c00621 · Cited by 15 · see citing works
Self-citationBinding studies of potential amyloid-β inhibiting chalcone derivative with bovine serum albumin
Daksh, S., Gond, C., Kumar, N., Kaur, L., Ojha, H., Deep, S., & Datta, A. (2023) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2023.123362 · Cited by 13 · see citing works
Zhang, T., Pauly, T. A., & Nagel‐Steger, L. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.02.123 · Cited by 13 · see citing works
Telpoukhovskaia, M. A., Rodríguez‐Rodríguez, C., Scott, L. E., Page, B. D. G., Patrick, B. O., & Orvig, C. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.12.003 · Cited by 13 · see citing works
Zhao, S., Wang, L., Liang, J., et al. (2024) · Journal of Food Science · doi:10.1111/1750-3841.17160 · Cited by 11 · see citing works
Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease
Okafor, M., Faller, P., & Vitale, N. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00504-6 · Cited by 15 · see citing works
“Nonetheless, Zn has been shown to promote the formation of amorphous, non-fibrillar Aβ aggregates [133–135].”
Atrián‐Blasco, E., Cerrada, E., Faller, P., Laguna, M., & Hureau, C. (2019) · Metallomics · doi:10.1039/c9mt00011a · Cited by 12 · see citing works
Knez, D., Sosič, I., Pišlar, A. H., Mitrović, A., Jukič, M., Kos, J., & Gobec, S. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191010130351 · Cited by 11 · see citing works
Molecular Insights into Cu/Zn Metal Response to the Amyloid β-Peptide (1–42)
Sunda, A. P., & Sharma, A. K. (2023) · ACS Physical Chemistry Au · doi:10.1021/acsphyschemau.3c00041 · Cited by 10 · see citing works
Self-citation
- Authors
- Sharma, A. K., Pavlova, S. T., Kim, J., Kim, J., & Mirica, L. M.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Mirica, Liviu M.
- Venue
- Metallomics
- Publisher
- Oxford University Press (OUP)
- Published
- 2013
- Volume
- 5
- Issue
- 11
- Pages
- 1529
- ISSN
- 1756-5901 (ISSN-L)
- 1756-591X
- PMC
- PMC4060528
- OpenAlex
- W2027527679
- Semantic Scholar
- 979734017be9e607107cd2303763e2725cc3e615
- Cited by
- 135
- References
- 64
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 12 · 2023: 8 · 2022: 20 · 2021: 5 · 2020: 15 · 2019: 11 · 2018: 9 · 2017: 11 · 2016: 11 · 2015: 9 · 2014: 9 · 2013: 1
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Metallomics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health (5p41rr000954-34)
- National Center for Research Resources (P41-RR000954)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid-beta 42, copper ions, zinc ions, metal-peptide coordination, peptide aggregation, oligomerization, fibrillization, neurotoxicity, Alzheimer's disease, amorphous aggregates
- MeSH terms
- Animals, Cell Survival, Copper, Fluorescence, Protein Binding, Thiazoles, Zinc, Amyloid beta-Peptides, Cell Line, Tumor, Mice, Benzothiazoles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-17.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-17.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review